Miach Orthopaedics closed a $20 million Series B extension financing round. Funds will support commercial expansion and clinical activities for the Bridge-Enhanced ACL Restoration (BEAR) Implant, which has been used to treat nearly 3,000 patients with anterior cruciate ligament (ACL) tears.
BEAR enables a torn ACL to heal and restores the natural function of the knee. It offers an alternative to the current standard of care – reconstruction that replaces the ACL with a graft.
The Major League Soccer Players Association, SV Health Investors and Aperture Venture Partners join existing investors Amzak Health, Smith+Nephew, DSM Venturing, Sectoral Asset Management, Endeavour Vision and the NFL Players Association in the extension round. S
“This financing will enable continued growth of our commercial organization in the U.S., as well as support clinical initiatives like the Bridge Registry to provide important data on real-world patient outcomes,” said Patrick McBrayer, President and CEO, Miach Orthopaedics. “We are excited to welcome the MLSPA, whose investment demonstrates the potential of the BEAR Implant to be a game changer for professional athletes, as well as SV Health Investors and Aperture Venture Partners.”
Miach Orthopaedics closed a $20 million Series B extension financing round. Funds will support commercial expansion and clinical activities for the Bridge-Enhanced ACL Restoration (BEAR) Implant, which has been used to treat nearly 3,000 patients with anterior cruciate ligament (ACL) tears.
BEAR enables a torn ACL to heal and restores the...
Miach Orthopaedics closed a $20 million Series B extension financing round. Funds will support commercial expansion and clinical activities for the Bridge-Enhanced ACL Restoration (BEAR) Implant, which has been used to treat nearly 3,000 patients with anterior cruciate ligament (ACL) tears.
BEAR enables a torn ACL to heal and restores the natural function of the knee. It offers an alternative to the current standard of care – reconstruction that replaces the ACL with a graft.
The Major League Soccer Players Association, SV Health Investors and Aperture Venture Partners join existing investors Amzak Health, Smith+Nephew, DSM Venturing, Sectoral Asset Management, Endeavour Vision and the NFL Players Association in the extension round. S
“This financing will enable continued growth of our commercial organization in the U.S., as well as support clinical initiatives like the Bridge Registry to provide important data on real-world patient outcomes,” said Patrick McBrayer, President and CEO, Miach Orthopaedics. “We are excited to welcome the MLSPA, whose investment demonstrates the potential of the BEAR Implant to be a game changer for professional athletes, as well as SV Health Investors and Aperture Venture Partners.”
Copy to clipboard 
